GDP	0	3	B-Drug_or_compound
and	4	7	O
AGE	8	11	B-Drug_or_compound
receptors	12	21	O
:	21	22	O
mechanisms	23	33	O
of	34	36	O
peritoneal	37	47	B-Multi-tissue_structure
damage	48	54	O
.	54	55	O

Long	57	61	O
-	61	62	O
term	62	66	O
peritoneal	67	77	O
dialysis	78	86	O
(	87	88	O
PD	88	90	O
)	90	91	O
is	92	94	O
limited	95	102	O
by	103	105	O
morphological	106	119	O
changes	120	127	O
of	128	130	O
the	131	134	O
peritoneal	135	145	B-Multi-tissue_structure
membrane	146	154	I-Multi-tissue_structure
.	154	155	O

Structural	156	166	O
changes	167	174	O
were	175	179	O
promoted	180	188	O
by	189	191	O
toxicity	192	200	O
of	201	203	O
glucose	204	211	B-Drug_or_compound
degradation	212	223	I-Drug_or_compound
products	224	232	I-Drug_or_compound
(	233	234	O
GDPs	234	238	B-Drug_or_compound
)	238	239	O
which	240	245	O
are	246	249	O
generated	250	259	O
during	260	266	O
heat	267	271	O
sterilization	272	285	O
in	286	288	O
peritoneal	289	299	O
dialysis	300	308	O
fluids	309	315	O
(	316	317	O
PDFs	317	321	O
)	321	322	O
.	322	323	O

Besides	324	331	O
their	332	337	O
direct	338	344	O
toxicity	345	353	O
GDPs	354	358	B-Drug_or_compound
promote	359	366	O
formation	367	376	O
of	377	379	O
advanced	380	388	B-Drug_or_compound
glycation	389	398	I-Drug_or_compound
endproducts	399	410	I-Drug_or_compound
(	411	412	O
AGEs	412	416	B-Drug_or_compound
)	416	417	O
.	417	418	O

RAGE	419	423	B-Gene_or_gene_product
(	424	425	O
receptor	425	433	B-Gene_or_gene_product
for	434	437	I-Gene_or_gene_product
AGE	438	441	I-Gene_or_gene_product
)	441	442	O
is	443	445	O
the	446	449	O
best	450	454	O
characterized	455	468	O
signal	469	475	O
transduction	476	488	O
receptor	489	497	O
for	498	501	O
AGEs	502	506	B-Drug_or_compound
and	507	510	O
is	511	513	O
expressed	514	523	O
on	524	526	O
mesothelial	527	538	B-Cell
cells	539	544	I-Cell
.	544	545	O

The	546	549	O
effects	550	557	O
of	558	560	O
PDFs	561	565	O
with	566	570	O
different	571	580	O
amounts	581	588	O
of	589	591	O
GDPs	592	596	B-Drug_or_compound
were	597	601	O
compared	602	610	O
on	611	613	O
morphological	614	627	O
changes	628	635	O
in	636	638	O
the	639	642	O
peritoneal	643	653	B-Multi-tissue_structure
membrane	654	662	I-Multi-tissue_structure
in	663	665	O
a	666	667	O
RAGE	668	672	B-Gene_or_gene_product
-	673	674	O
/	674	675	O
-	675	676	O
mouse	677	682	O
model	683	688	O
.	688	689	O

It	690	692	O
could	693	698	O
be	699	701	O
demonstrated	702	714	O
that	715	719	O
RAGE	720	724	B-Gene_or_gene_product
plays	725	730	O
a	731	732	O
pivotal	733	740	O
role	741	745	O
in	746	748	O
structural	749	759	O
damage	760	766	O
(	767	768	O
e	768	769	O
.	769	770	O
g	770	771	O
.	771	772	O
inflammation	773	785	O
,	785	786	O
neoangiogenesis	787	802	O
and	803	806	O
fibrosis	807	815	O
)	815	816	O
of	817	819	O
the	820	823	O
peritoneal	824	834	B-Multi-tissue_structure
membrane	835	843	I-Multi-tissue_structure
.	843	844	O

Further	845	852	O
investigations	853	867	O
of	868	870	O
this	871	875	O
pathway	876	883	O
with	884	888	O
regard	889	895	O
to	896	898	O
preventing	899	909	O
peritoneal	910	920	B-Multi-tissue_structure
fibrosis	921	929	O
should	930	936	O
be	937	939	O
performed	940	949	O
to	950	952	O
maintain	953	961	O
the	962	965	O
integrity	966	975	O
of	976	978	O
the	979	982	O
peritoneal	983	993	B-Multi-tissue_structure
membrane	994	1002	I-Multi-tissue_structure
in	1003	1005	O
peritoneal	1006	1016	B-Multi-tissue_structure
dialysis	1017	1025	O
patients	1026	1034	B-Organism
.	1034	1035	O

